• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症额皮质下通路异常及抗精神病药物治疗的差异影响:基于弥散张量成像的轨迹研究。

Abnormalities of fronto-subcortical pathways in schizophrenia and the differential impacts of antipsychotic treatment: a DTI-based tractography study.

机构信息

ISTS EA 7466, Normandie Université, UNICAEN, Caen, France.

ISTS EA 7466, Normandie Université, UNICAEN, Caen, France; Service de Psychiatrie Adulte, Centre Esquirol, CHU de Caen, 14000 Caen, France; UFR de Médecine (Medical School), Normandie Université, UNICAEN, Caen, France.

出版信息

Psychiatry Res Neuroimaging. 2018 Oct 30;280:22-29. doi: 10.1016/j.pscychresns.2018.08.008. Epub 2018 Aug 17.

DOI:10.1016/j.pscychresns.2018.08.008
PMID:30145382
Abstract

The fronto-striato-thalamic circuitry is a key network in patients with schizophrenia (SZPs). We use diffusion tensor imaging (DTI) to investigate the integrity of white matter (WM) pathways involved in this network in SZPs relative to healthy controls (HCs). We also evaluate the differential impact of chronic exposure to clozapine as well as other atypical and typical antipsychotics. 63 HCs and 41 SZPs were included. Of the SZPs, 16 were treated with clozapine (SZPsC), 17 with atypical antipsychotics (SZPsA), and 8 with typical antipsychotics (SZPsT). Three tracts were reconstructed in the left hemisphere using tractography: one fronto-subcortical tract, one prefronto-subcortical tract, and one prefronto-frontal tract. Diffusion parameters were individually extracted in each tract. SZPs exhibited lower integrity in both the fronto-subcortical and prefronto-subcortical tracts relative to HCs, and SZPsT showed altered integrity compared to SZPsC. There were no WM integrity differences in the prefronto-frontal tract between SZP groups or between SZPs and HCs. SZPs exhibit structural connectivity abnormalities in the prefronto-fronto-subcortical network that are specifically and differentially impacted by the type of antipsychotic treatment. Additional studies are needed to separate the contributions of clozapine-mediated neuroprotection, neurotoxicity related to typical antipsychotics, and the illness itself to observed differences.

摘要

额纹体丘脑回路是精神分裂症患者(SZP)的关键网络。我们使用弥散张量成像(DTI)来研究与健康对照者(HC)相比,SZP 中涉及该网络的白质(WM)通路的完整性。我们还评估了氯氮平以及其他非典型和典型抗精神病药物的慢性暴露的差异影响。纳入 63 名 HCs 和 41 名 SZP。其中 16 名 SZP 接受氯氮平治疗(SZPsC),17 名 SZP 接受非典型抗精神病药物治疗(SZPsA),8 名 SZP 接受典型抗精神病药物治疗(SZPsT)。使用轨迹重建方法在左半球重建了 3 条束:1 条额皮质下束、1 条额皮质下束和 1 条额额束。在每个束中单独提取扩散参数。与 HCs 相比,SZP 显示出额皮质下束和额皮质下束的完整性降低,SZPsT 与 SZPsC 相比,完整性改变。SZP 组或 SZP 与 HCs 之间在额额束中没有 WM 完整性差异。SZP 在前额额皮质下网络中表现出结构连接异常,这种异常特异性地且差异地受到抗精神病药物治疗类型的影响。需要进一步的研究来分离氯氮平介导的神经保护、与典型抗精神病药物相关的神经毒性以及疾病本身对观察到的差异的贡献。

相似文献

1
Abnormalities of fronto-subcortical pathways in schizophrenia and the differential impacts of antipsychotic treatment: a DTI-based tractography study.精神分裂症额皮质下通路异常及抗精神病药物治疗的差异影响:基于弥散张量成像的轨迹研究。
Psychiatry Res Neuroimaging. 2018 Oct 30;280:22-29. doi: 10.1016/j.pscychresns.2018.08.008. Epub 2018 Aug 17.
2
Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study.氯氮平对精神分裂症患者脑白质完整性的影响:一项弥散张量成像研究。
Psychiatry Res. 2014 Sep 30;223(3):226-35. doi: 10.1016/j.pscychresns.2014.06.001. Epub 2014 Jun 20.
3
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study.重度治疗抵抗性精神分裂症患者的脑白质微观结构组织:一项弥散张量成像研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109871. doi: 10.1016/j.pnpbp.2020.109871. Epub 2020 Jan 18.
4
Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.未用药的首发精神分裂症患者在抗精神病药物治疗八周前后的白质微观结构异常。
Schizophr Res. 2016 Apr;172(1-3):1-8. doi: 10.1016/j.schres.2016.01.051. Epub 2016 Feb 3.
5
Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.氯氮平或利培酮治疗与未治疗慢性精神分裂症患者的脑白质结构网络特征。
Int J Neuropsychopharmacol. 2020 Dec 29;23(12):799-810. doi: 10.1093/ijnp/pyaa061.
6
Formal thought disorder is related to aberrations in language-related white matter tracts in patients with schizophrenia.形式思维障碍与精神分裂症患者语言相关白质束的异常有关。
Psychiatry Res Neuroimaging. 2018 Sep 30;279:40-50. doi: 10.1016/j.pscychresns.2018.05.011. Epub 2018 May 23.
7
White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs.精神分裂症中的白质破坏在空间上广泛存在且在拓扑结构上汇聚于脑网络枢纽。
Schizophr Bull. 2017 Mar 1;43(2):425-435. doi: 10.1093/schbul/sbw100.
8
White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia.在未使用过药物的精神分裂症患者中,氨磺必利治疗后,白质完整性与阳性症状严重程度降低相关。
Neurosci Lett. 2018 Oct 15;685:131-136. doi: 10.1016/j.neulet.2018.08.036. Epub 2018 Aug 26.
9
Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia.精神分裂症治疗抵抗和治疗反应亚型之间的白质连通性差异。
Psychiatry Res Neuroimaging. 2018 Dec 30;282:47-54. doi: 10.1016/j.pscychresns.2018.11.002. Epub 2018 Nov 3.
10
Callosal and subcortical white matter alterations in schizophrenia: A diffusion tensor imaging study at multiple levels.精神分裂症患者胼胝体和皮质下白质的改变:在多个层面的弥散张量成像研究。
Neuroimage Clin. 2018 Aug 24;20:594-602. doi: 10.1016/j.nicl.2018.08.027. eCollection 2018.

引用本文的文献

1
Effects of Adapted Physical Activity on White Matter Integrity in Patients with Schizophrenia.适应性体育活动对精神分裂症患者白质完整性的影响。
Brain Sci. 2024 Jul 15;14(7):710. doi: 10.3390/brainsci14070710.
2
Resting-state functional MRI in treatment-resistant schizophrenia.难治性精神分裂症的静息态功能磁共振成像
Front Neuroimaging. 2023 Apr 6;2:1127508. doi: 10.3389/fnimg.2023.1127508. eCollection 2023.
3
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients.
精神分裂症中额纹状体连接与纹状体多巴胺功能的关系:一项针对治疗反应性和难治性患者的18F-DOPA正电子发射断层扫描及扩散张量成像研究
Psychiatry Investig. 2022 Jul;19(7):570-579. doi: 10.30773/pi.2022.0033. Epub 2022 Jul 21.
4
Characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated.氯氮平或利培酮治疗与未治疗的慢性精神分裂症患者胼胝体特征
BMC Psychiatry. 2021 Oct 30;21(1):538. doi: 10.1186/s12888-021-03552-0.
5
Structural Differences Between Healthy Subjects and Patients With Schizophrenia or Schizoaffective Disorder: A Graph and Control Theoretical Perspective.健康受试者与精神分裂症或分裂情感性障碍患者之间的结构差异:基于图论与控制理论的视角
Front Psychiatry. 2021 Jun 28;12:669783. doi: 10.3389/fpsyt.2021.669783. eCollection 2021.
6
Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.未经治疗的首发精神分裂症患者的认知缺陷和白质异常。
Transl Psychiatry. 2020 Nov 2;10(1):368. doi: 10.1038/s41398-020-01049-0.
7
Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.氯氮平对精神分裂症患者脑结构和功能的影响:神经影像学纵向研究的系统评价。
Can J Psychiatry. 2021 Aug;66(8):683-700. doi: 10.1177/0706743720966459. Epub 2020 Nov 2.
8
Magnetic resonance diffusion tensor imaging in psychiatry: a narrative review of its potential role in diagnosis.磁共振弥散张量成像在精神病学中的应用:诊断潜在作用的叙述性综述。
Pharmacol Rep. 2021 Feb;73(1):43-56. doi: 10.1007/s43440-020-00177-0. Epub 2020 Oct 30.
9
Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.氯氮平或利培酮治疗与未治疗慢性精神分裂症患者的脑白质结构网络特征。
Int J Neuropsychopharmacol. 2020 Dec 29;23(12):799-810. doi: 10.1093/ijnp/pyaa061.
10
Subtle white matter alterations in schizophrenia identified with a new measure of fiber density.利用一种新的纤维密度测量方法发现精神分裂症中的细微的脑白质改变。
Sci Rep. 2019 Mar 15;9(1):4636. doi: 10.1038/s41598-019-40070-2.